What’s the Impact of FDA Draft Guidance on Wholesaling Compounded Drugs?

By Gina Shaw

Community pharmacists, 503B drug compounding facilities and other stakeholders are arguing whether proposed guidance from the FDA on wholesaling compounded drugs goes too far or not far enough in restricting how these products are sold and to whom.